Technical Analysis - ADMA Biologics Inc has reached a key level of support, with its 50-day simple moving average crossing above the 200-day simple moving average, indicating a "golden cross" [1] - A golden cross is a bullish technical chart pattern that suggests a potential breakout, formed when a stock's short-term moving average surpasses its long-term moving average [1][2] Market Performance - ADMA has experienced a rally of 31% over the past four weeks, indicating strong upward momentum [3] - The company currently holds a 2 (Buy) rating on the Zacks Rank, suggesting positive market sentiment [3] Earnings Outlook - The earnings outlook for ADMA is positive, with no earnings estimates decreasing in the past two months and two revisions higher, leading to an increase in the Zacks Consensus Estimate [3] - This positive earnings outlook further solidifies the bullish case for ADMA [3] Investment Consideration - Investors are encouraged to consider adding ADMA to their watchlist due to the significant technical indicator and the positive movement in earnings estimates [4]
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy?